Liu, W., Zhuang, C., Huang, T., Yang, S., Zhang, M., Lin, B., & Jiang, Y. (2020). Loss of CDKN2A at chromosome 9 has a poor clinical prognosis and promotes lung cancer progression. Wiley.
Chicago-Zitierstil (17. Ausg.)Liu, Wei, Congwen Zhuang, Tengfei Huang, Shengsheng Yang, Meiqing Zhang, Baoquan Lin, und Yi Jiang. Loss of CDKN2A at Chromosome 9 Has a Poor Clinical Prognosis and Promotes Lung Cancer Progression. Wiley, 2020.
MLA-Zitierstil (9. Ausg.)Liu, Wei, et al. Loss of CDKN2A at Chromosome 9 Has a Poor Clinical Prognosis and Promotes Lung Cancer Progression. Wiley, 2020.
Achtung: Diese Zitate sind unter Umständen nicht zu 100% korrekt.